Table 1.
Patient Demographics and Baseline Characteristicsa
| Variable | AsAMR | TxAMR | Control |
|---|---|---|---|
| No. | 21 | 22 | 86 |
| Female, No. (%) | 9 (43) | 9 (41) | 34 (40) |
| Recipient age at Tx, mean ± SD, years |
54 ± 13 | 50 ± 14 | 52 ± 14 |
| Ischemic time, mean ± SD, min | 218 ± 77 | 204 ± 56 | 220 ± 84 |
| Donor female, No. (%) | 10 (48) | 5 (22) | 34 (40) |
| Donor, mean age ± SD, years | 38 ± 12 | 33 ± 13 | 31 ± 12 |
| CMV mismatch D+/R−, No. (%) | 3 (18) | 0 | 14 (16) |
AsAMR, asymptomatic antibody-mediated rejection; CMV, cytomegalovirus; SD, standard deviation; TxAMR, treated antibody-mediated rejection.
a
No significant differences in any baseline characteristics.